Impact of Monoclonal Antibody Treatment on Post-Acute COVID-19 Syndrome

Clinical trial NCT05013723 · COMPLETED

Trial details

NCT number: NCT05013723
Sponsor: Intermountain Health Care, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Post-acute COVID-19 (PACS), or "long COVID" Syndrome

Start date: 2021-08-30
Primary completion: 2022-12-16
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.